semaglutide

Yale study finds drugs and diet slow aging but supplements don’t

A new Yale-led study published in Nature Medicine on August 21 has identified which anti-aging interventions produce measurable reductions in biological age — and which do not. The research arrives amid growing scientific interest in longevity, including a separate study…

Novo Nordisk partners with Vivani on semaglutide implant

Novo Nordisk has signed an agreement with Vivani Medical to evaluate NPM-139, a miniature subdermal semaglutide implant designed to deliver medication steadily over extended periods, the companies announced on Monday. The deal marks an effort by the Danish pharmaceutical giant…